SynthesisJournal of human hypertension2014
Prevalence and characteristics of hypertension in mainland Chinese adults over decades: a systematic review.
Synthesis in Journal of human hypertension, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence of hypertension and related risk factors in older Chinese population: a meta-analysis.Frontiers in public health · 2024Pooled it
- Trial
- The impact of marital status on hypertension: SEM analysis of a Chinese general population cohort.BMC public health · 2025Article
- The quality and reliability of short videos about hypertension on TikTok: a cross-sectional study.Scientific reports · 2025Article
- Impact of multi-metal exposure on blood pressure: a mediation analysis through oxidative stress markers in China's Southern Jiangxi Province.BMC public health · 2025Article
- Agreement between self-reported and objectively measured hypertension diagnosis and control: evidence from a nationally representative sample of community-dwelling middle-aged and older adults in China.Archives of public health = Archives belges de sante publique · 2024Article
- The association between circulating short-chain fatty acids and blood pressure in Chinese elderly population.Scientific reports · 2024Article
- Using routinely collected data to determine care cascades of hypertension and type-2 diabetes management in China: a cross-sectional study.The Lancet regional health. Western Pacific · 2024Article
- Article
- Analysis of prescription status of antihypertensive drugs in Chinese patients with hypertension based on real-world study.Annals of medicine · 2023Article
- A glimpse into the future: modelling global prevalence of hypertension.BMC public health · 2023Article
- Trends in output of hypertension management and associated factors in primary care facilities: a latent trajectory analysis in China from 2009 to 2017.BMC primary care · 2023Article
- Prevalence, awareness, treatment, and control of hypertension and their risk factors in Shaanxi Province in 2004-18.Scientific reports · 2023Article
- Association of multi-metals with the risk of hypertension and the interaction with obesity: A cross-sectional study in China.Frontiers in public health · 2023Article
- Body mass index trajectory from childhood to puberty and high blood pressure: the China Health and Nutrition Survey.BMJ open · 2021Article
- Changes in the prevalence of obesity and hypertension and demographic risk factor profiles in China over 10 years: two national cross-sectional surveys.The Lancet regional health. Western Pacific · 2021Article
- Article
- Factors affecting health care users' first contact with primary health care facilities in north eastern China, 2008-2018.BMJ global health · 2021Article
- Distribution of risk factors of hypertension patients in different age groups in Tianjin.BMC public health · 2021Article
- Hypertension Prevalence Rates Among Urban and Rural Older Adults of China, 1991-2015: A Standardization and Decomposition Analysis.Frontiers in public health · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertension is considered to be the leading risk factor for cardiovascular mortality and accounts for a large proportion of premature deaths in China. An empirical understanding of the pattern of disease burden, such as reliable information about the trend and prevalence of hypertension, is essential in developing effective prevention and control strategies and is also important in the decision-making and planning processes of health. However, there are limited comprehensive reviews or nationwide studies that reveal the current burden of hypertension in China. This review is to systematically evaluate hypertension prevalence and determinants as well as its awareness, treatment and control over decades in China. A systematic search was performed for epidemiological studies on hypertension, published between 1982 and January 2013. MeSH major topic terms 'hypertension' and 'prevalence' and 'China' were used in the search. Data on hypertension prevalence, determinants and awareness, as well as its treatment and control, were extracted and compared. Sixty articles were included for data extraction. The prevalence reported in the studies varied from 7.17 to 51.2%. Awareness, treatment and control rates also varied regionally. Except in the central region of China, where a declining trend in hypertension prevalence was witnessed, a rising trend in hypertension prevalence over time could still be observed in other parts of China. Higher hypertension prevalence was found among men and in the urban population, whereas lower prevalence was found in the southern region. Hypertension awareness and treatment rate varied extensively, with a low control rate, nationwide.
Indexed as
Identifiers
24573131What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.